论文部分内容阅读
本文合成了吗啉双胍合锌配合物。经分析鉴定,锌离子、吗啉双胍、氯离子组成比为1:1:3,分子式确定为[Zn(C_6H_(14)N_5O)Cl_3]。对该配合物的红外光谱、核磁共振氢谱、~(13)C、~(15)N谱进行了研究。获得了该配合物的单晶体,结构研究表明,该晶体属于三斜晶系,空间群为P1,晶胞参数:a=7.696(3)、b=7.773(2)、c=12。074(5)A;α=74.95(3),β=81.29(3),γ=66.89(3)度。晶胞中含有二个[Zn(C_6H_(14)N_5O)Cl_3]分子,锌与吗啉双胍呈单齿配位,每个锌离子除与吗啉双胍中N(3)原子配位外,还有三个氯离子参与配位成四面体构型.
In this paper, morpholine biguanide zinc complexes were synthesized. After analysis and identification, zinc, morpholine biguanide, chloride ion composition ratio of 1: 1: 3, the formula identified as [Zn (C_6H_ (14) N_5O) Cl_3]. The IR, 1HNMR, ~ (13) C, ~ (15) N spectra of the complex were studied. The crystal structure of the crystal belongs to the triclinic system with space group P1 and unit cell parameters: a = 7.696 (3), b = 7.773 (2), c = 12.074 (5) ) A; α = 74.95 (3), β = 81.29 (3), γ = 66.89 (3) degrees. The unit cell contains two [Zn (C_6H_ (14) N_5O) Cl_3] molecules. Zinc and morpholine biguanide are monodentate. Each zinc ion is coordinated with the N (3) atom in morpholine biguanide There are three chloride ions involved in the formation of tetrahedral configuration.